Ectopic Endometrium-Targeted M1 Macrophage-Derived Nanovesicles for Treatment of Endometriosis
ACS Applied Bio Materials · 2026
DOI: 10.1021/acsabm.6c00680 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2026. Verfasst von Yaping Xing und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hangzhou Medical College, Hangzhou, Zhejiang310053, People's Republic of China. Hauptthemen laut MEDLINE: Endometriosis, Macrophages, Indoles, Nanoparticles. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Endometriosis (EMs) is a common gynecological disorder in women of reproductive age, often presenting with pelvic pain and infertility. Its progression is closely linked to estrogen levels. While hormonal therapies are effective, long-term use can disrupt systemic hormone balance. To address this, we developed M1 macrophage membrane-derived nanovesicles (M1NVs) that leverage the natural CCL2-CCR2 targeting axis to selectively deliver drugs to ectopic endometrial lesions. The estrogen receptor antagonist bazedoxifene (BAZ) was encapsulated into M1NVs, enabling targeted delivery to ectopic tissue following systemic administration. This approach locally antagonizes estrogen signaling, resulting in effective attenuation of inflammatory infiltration, suppression of angiogenesis, and reduction of fibrosis, thereby inhibiting the growth of ectopic endometrial tissue. Importantly, it did not adversely affect ovarian or uterine structure and function. This strategy offers a targeted and efficient alternative for the treatment of endometriosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Hangzhou Medical College, Hangzhou, Zhejiang310053, People's Republic of China.
- Children's Hospital, Zhejiang University School of Medicine , Hangzhou, Zhejiang310052, People's Republic of China.
- Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang310006, People's Republic of China.
- College of Pharmaceutical Science, Zhejiang University, Hangzhou, Zhejiang310058, People's Republic of China.
ORCID-Profile: Hong Yuan, Tingting Meng
Zitieren
APA
Xing, Y., Zhang, F., Zhao, M., Zhang, H., Yuan, H., & Meng, T. (2026). Ectopic Endometrium-Targeted M1 Macrophage-Derived Nanovesicles for Treatment of Endometriosis. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c00680
Vancouver
Xing Y, Zhang F, Zhao M, Zhang H, Yuan H, Meng T. Ectopic Endometrium-Targeted M1 Macrophage-Derived Nanovesicles for Treatment of Endometriosis. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c00680
BibTeX
@article{Xing2026,
author = {Xing, Yaping and Zhang, Fanhui and Zhao, Mengdan and Zhang, Hanbo and Yuan, Hong and Meng, Tingting},
title = {Ectopic Endometrium-Targeted M1 Macrophage-Derived Nanovesicles for Treatment of Endometriosis},
journal = {ACS Applied Bio Materials},
year = {2026},
doi = {10.1021/acsabm.6c00680}
}
EUVIMED